Skip to content
2000
Volume 32, Issue 39
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Hypertension, characterized by elevated blood pressure levels, remains a global health concern due to its association with cardiovascular complications, notably thrombosis. Thrombosis, the formation of blood clots within blood vessels, poses a significant risk for myocardial infarction, stroke, and limb ischemia, leading to adverse patient outcomes. Understanding the pathophysiological mechanisms underlying thrombosis in hypertension is crucial for developing effective preventive and therapeutic strategies. Hypertension induces structural and functional alterations in the vasculature, endothelium, and platelets, creating a prothrombotic milieu. Endothelial dysfunction, increased platelet activation, and alterations in coagulation factors contribute to the heightened thrombotic risk observed in hypertensive individuals. Biomarkers associated with thrombotic events, such as mean platelet volume, D-Dimer, and fibrinogen offer valuable insights into the pathogenesis of thrombosis and may serve as prognostic indicators for cardiovascular events in hypertensive populations. Investigating the impact of antihypertensive treatment on thrombotic risk is essential, as these medications exert pleiotropic effects on the vasculature and hemostatic system. By elucidating the intricate interplay between hypertension and thrombosis, this review aims to enhance our understanding of cardiovascular risk in hypertensive individuals and identify novel therapeutic targets for preventing thrombotic complications.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673324637240930140545
2024-10-16
2025-11-03

  • From This Site

    /content/journals/cmc/10.2174/0109298673324637240930140545
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. PsatyB.M. FurbergC.D. KullerL.H. CushmanM. SavageP.J. LevineD. O’LearyD.H. BryanR.N. AndersonM. LumleyT. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: The cardiovascular health study.Arch. Intern. Med.200116191183119210.1001/archinte.161.9.118311343441
     [Google Scholar]
  2. LuoD. ChengY. ZhangH. BaM. ChenP. LiH. ChenK. ShaW. ZhangC. ChenH. Association between high blood pressure and long term cardiovascular events in young adults: Systematic review and meta-analysis.BMJ2020370m322210.1136/bmj.m322232907799
     [Google Scholar]
  3. ElhaouariM. RosadoJ. Platelet function in hypertension.Blood Cells Mol. Dis.2009421384310.1016/j.bcmd.2008.07.00318829351
     [Google Scholar]
  4. TheofilisP. SagrisM. OikonomouE. AntonopoulosA.S. SiasosG. TsioufisC. TousoulisD. Inflammatory mechanisms contributing to endothelial dysfunction.Biomedicines20219778110.3390/biomedicines907078134356845
     [Google Scholar]
  5. HolmeP.A. ØrvimU. HamersM.J.A.G. SolumN.O. BrosstadF.R. BarstadR.M. SakariassenK.S. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis.Arterioscler. Thromb. Vasc. Biol.199717464665310.1161/01.ATV.17.4.6469108776
     [Google Scholar]
  6. RemkováA. RemkoM. The role of renin-angiotensin system in prothrombotic state in essential hypertension.Physiol. Res.2010591132310.33549/physiolres.93152519249905
     [Google Scholar]
  7. PretoriusL. ThomsonG.J.A. AdamsR.C.M. NellT.A. LaubscherW.A. PretoriusE. Platelet activity and hypercoagulation in type 2 diabetes.Cardiovasc. Diabetol.201817114110.1186/s12933‑018‑0783‑z30388964
     [Google Scholar]
  8. DavlourosP. XanthopoulouI. MparampoutisN. GiannopoulosG. DeftereosS. AlexopoulosD. Role of calcium in platelet activation: Novel insights and pharmacological implications.Med. Chem.201612213113810.2174/15734064120216020819592326411604
     [Google Scholar]
  9. MasselliE. PozziG. VaccarezzaM. MirandolaP. GalliD. VitaleM. CarubbiC. GobbiG. ROS in platelet biology: Functional aspects and methodological insights.Int. J. Mol. Sci.20202114486610.3390/ijms2114486632660144
     [Google Scholar]
  10. BlankenshipK.A. DawsonC.B. AronoffG.R. DeanW.L. Tyrosine phosphorylation of human platelet plasma membrane Ca(2+)-ATPase in hypertension.Hypertension200035110310710.1161/01.HYP.35.1.10310642282
     [Google Scholar]
  11. GkaliagkousiE. PassacqualeG. DoumaS. ZamboulisC. FerroA. Platelet activation in essential hypertension: implications for antiplatelet treatment.Am. J. Hypertens.201023322923610.1038/ajh.2009.24720094035
     [Google Scholar]
  12. LiJ. TongD. ChenF. SongB. WangY. LiuY. ZhangX. LiuN. XuY. LiY. YinX. LiuW. Inflammatory cytokines enhance procoagulant activity of platelets and endothelial cells through phosphatidylserine exposure in patients with essential hypertension.J. Thromb. Thrombolysis202151493394010.1007/s11239‑020‑02342‑x33219895
     [Google Scholar]
  13. KayaM.G. YarliogluesM. GunebakmazO. GunturkE. InancT. DoganA. KalayN. TopsakalR. Platelet activation and inflammatory response in patients with non-dipper hypertension.Atherosclerosis2010209127828210.1016/j.atherosclerosis.2009.09.01019782364
     [Google Scholar]
  14. GuvenA. CaliskanM. CiftciO. BarutcuI. Increased platelet activation and inflammatory response in patients with masked hypertension.Blood Coagul. Fibrinolysis201324217017410.1097/MBC.0b013e32835aba3623358199
     [Google Scholar]
  15. XuY. GuoY. Platelet indices and blood pressure: A multivariable mendelian randomization study.Thromb. J.20232113110.1186/s12959‑023‑00475‑636941692
     [Google Scholar]
  16. KjeldsenS.E. GjesdalK. EideI. AakessonI. AmundsenR. FossO.P. LerenP. Increased beta-thromboglobulin in essential hypertension: interactions between arterial plasma adrenaline, platelet function and blood lipids.Acta Med. Scand.1983213536937310.1111/j.0954‑6820.1983.tb03753.x6192689
     [Google Scholar]
  17. MehtaJ. MehtaP. Platelet function in hypertension and effect of therapy.Am. J. Cardiol.198147233133410.1016/0002‑9149(81)90405‑76451166
     [Google Scholar]
  18. KaralisI. NadarS.K. Al YemeniE. BlannA.D. LipG.Y.H. Platelet activation in pregnancy-induced hypertension.Thromb. Res.2005116537738310.1016/j.thromres.2005.01.00916122550
     [Google Scholar]
  19. AlouiC. PrigentA. SutC. TariketS. Hamzeh-CognasseH. PozzettoB. RichardY. CognasseF. LaradiS. GarraudO. The signaling role of CD40 ligand in platelet biology and in platelet component transfusion.Int. J. Mol. Sci.20141512223422236410.3390/ijms15122234225479079
     [Google Scholar]
  20. TousoulisD. AndroulakisE. PapageorgiouN. BriasoulisA. SiasosG. AntoniadesC. StefanadisC. From atherosclerosis to acute coronary syndromes: the role of soluble CD40 ligand.Trends Cardiovasc. Med.201020515316410.1016/j.tcm.2010.12.00421742271
     [Google Scholar]
  21. HuangY. JieL.I. ChenJ. TangS. HuangC. FengY. The relationship between soluble CD40 ligand level and atherosclerosis in white-coat hypertension.J. Hum. Hypertens.2018321404510.1038/s41371‑017‑0016‑z29162926
     [Google Scholar]
  22. FerroniP. GuagnanoM.T. FalcoA. PaolettiV. ManigrassoM.R. MichettiN. SantilliF. GuadagniF. BasiliS. DavìG. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.Clin. Sci. (Lond.)2008114644945510.1042/CS2007030717988217
     [Google Scholar]
  23. ÖzkanG. UlusoyS. MenteşeA. KarahanS.C. CansizM. New marker of platelet activation, SCUBE1, is elevated in hypertensive patients.Am. J. Hypertens.201326674875310.1093/ajh/hpt00723443724
     [Google Scholar]
  24. EbarM.H.O. AliA.G.A. AdanM.Q. AhmedA. IsseM.O.M. Measurement of plasma fibrinogen and D-dimer levels in sudanese hypertensive patients at Khartoum state.J. Drug Deliv. Ther.2022126485110.22270/jddt.v12i6.5791
     [Google Scholar]
  25. SechiL.A. ZingaroL. CatenaC. CasaccioD. De MarchiS. Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension.Hypertension200036697898510.1161/01.HYP.36.6.97811116111
     [Google Scholar]
  26. AgorastiA. TrivellasT. MourvatiE. PapadopoulosV. TsatalasK. VargemezisV. PassadakisP. D-dimer, factor VIII and von Willebrand factor predict a non-dipping pattern of blood pressure in hypertensive patients.Int. Urol. Nephrol.201345377778310.1007/s11255‑012‑0288‑823001640
     [Google Scholar]
  27. KhaleghiM. SaleemU. McBaneR.D. MosleyT.H.Jr KulloI.J. African-American ethnicity is associated with higher plasma levels of D-dimer in adults with hypertension.J. Thromb. Haemost.200971344010.1111/j.1538‑7836.2008.03215.x18983495
     [Google Scholar]
  28. Kamin MukazD. GuoB. LongD.L. JuddS.E. PlanteT.B. McClureL.A. WolbergA.S. ZakaiN.A. HowardG. CushmanM. D-dimer and the risk of hypertension: The reasons for geographic and racial differences in stroke cohort study.Res. Pract. Thromb. Haemost.20237110001610.1016/j.rpth.2022.10001636760775
     [Google Scholar]
  29. KimB.S. ShinJ.H. Association between D-dimer and long-term mortality in patients with acute severe hypertension visiting the emergency department.Clin. Hypertens.20232911610.1186/s40885‑023‑00244‑737316924
     [Google Scholar]
  30. PapadopoulosD.P. ThomopoulosC. MourouzisI. KotrotsouA. SanidasE. PapazachouU. DaskalakiM. MakrisT.K. Masked hypertension unfavourably affects haemostasis parameters.Blood Press.201120421822110.3109/08037051.2011.56555121388252
     [Google Scholar]
  31. JaeS.Y. KurlS. LaukkanenJ.A. LeeC.D. ChoiY.H. FernhallB. FranklinB.A. Relation of C-reactive protein, fibrinogen, and cardiorespiratory fitness to risk of systemic hypertension in men.Am. J. Cardiol.2015115121714171910.1016/j.amjcard.2015.03.01625888302
     [Google Scholar]
  32. ShankarA. WangJ.J. RochtchinaE. MitchellP. Positive association between plasma fibrinogen level and incident hypertension among men: Population-based cohort study.Hypertension20064861043104910.1161/01.HYP.0000245700.13817.3c17000922
     [Google Scholar]
  33. KolzM. BaumertJ. GohlkeH. GrallertH. DöringA. PetersA. WichmannE. IlligT. KoenigW. Association study between variants in the fibrinogen gene cluster, fibrinogen levels and hypertension: Results from the MONICA/ KORA study.Thromb. Haemost.2009101231732410.1160/TH08‑06‑041119190816
     [Google Scholar]
  34. BothaS. FourieC.M.T. SchutteR. Eugen-OlsenJ. SchutteA.E. Soluble urokinase plasminogen activator receptor and hypertension among black South Africans after 5 years.Hypertens. Res.201538643944410.1038/hr.2015.2225740290
     [Google Scholar]
  35. Ayala-RamírezP. BuitragoT. PovedaA. RodríguezJ.L. Olaya-CM. García-RoblesR. Increased tissue factor and thrombomodulin expression and histopathological changes in placentas of pregnancies with preeclampsia.J. Neonatal Perinatal Med.201691313910.3233/NPM‑1691503427002259
     [Google Scholar]
  36. HsuC. CopelJ. HongS. ChanD. Thrombomodulin levels in preeclampsia, gestational hypertension, and chronic hypertension.Obstet. Gynecol.199586689789910.1016/0029‑7844(95)00326‑M7501335
     [Google Scholar]
  37. Ayala-RamírezP. GámezT. Castro-PontónD.L. SilvaJ. García-RoblesR. Olaya-CM. Expression of tissue factor and thrombomodulin in the placentas of pregnancies affected by early-onset and late-onset preeclampsia.J. Obstet. Gynaecol. Res.20214772307231710.1111/jog.1479333876519
     [Google Scholar]
  38. LuoJ. YangT. DingL. XiongJ.H. YingT. XuF. Relevant detection indicator of prethrombotic state in patients with primary hypertension.World J. Clin. Cases202311245678569110.12998/wjcc.v11.i24.567837727711
     [Google Scholar]
  39. GuoX.Q. RenW. PengR. LiuY.H. LiY. Clinical application of endothelial injury marker in hypertensive patients.J. Clin. Lab. Anal.2018325e2238710.1002/jcla.2238729575096
     [Google Scholar]
  40. AlexandruN. PopovD. DraganE. AndreiE. GeorgescuA. Platelet activation in hypertension associated with hypercholesterolemia: Effects of irbesartan.J. Thromb. Haemost.20119117318410.1111/j.1538‑7836.2010.04122.x20961397
     [Google Scholar]
  41. WuF. WangH.Y. CaiF. WangL.J. ZhangF.R. ChenX.N. YangQ. JiangM.H. WangX.F. ShenW.F. Valsartan decreases platelet activity and arterial thrombotic events in elderly patients with hypertension.Chin. Med. J. (Engl.)2015128215315810.4103/0366‑6999.14918525591555
     [Google Scholar]
  42. RostagnoC. ColellaA. ChiarantiniE. PriscoD. GensiniG.F. Effects of amlodipine on platelet aggregation in hypertensive patients.Clin. Drug Investig.19959525525910.2165/00044011‑199509050‑00002
     [Google Scholar]
  43. OshimaT. OnoN. OzonoR. HigashiY. IshidaM. IshidaT. MihoN. NakashimaH. YanoY. KambeM. Effect of amlodipine and cilazapril treatment on platelet Ca2+ handling in spontaneously hypertensive rats.Hypertens. Res.2003261190190610.1291/hypres.26.90114714582
     [Google Scholar]
  44. CelikT. YukselU.C. IyisoyA. KursakliogluH. OzcanO. KilicS. OzmenN. IsikE. Effects of nebivolol on platelet activation in hypertensive patients: A comparative study with metoprolol.Int. J. Cardiol.2007116220621110.1016/j.ijcard.2006.03.04616822563
     [Google Scholar]
/content/journals/cmc/10.2174/0109298673324637240930140545
Loading
Thrombosis in Hypertension: Pathophysiology, Biomarkers, and the Effect of Antihypertensive Treatment
Curr. Med. Chem. 32, 8885 (2025); https://doi.org/10.2174/0109298673324637240930140545
/content/journals/cmc/10.2174/0109298673324637240930140545
/content/journals/cmc/10.2174/0109298673324637240930140545
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): coagulation; D-dimer; fibrinogen; Hypertension; platelet; thrombosis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test